Based on the SMILES representation NC(=O)c1csc([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1, the molecule has a half life in humans after IV administration of 5.900 hours.
Based on the {SMILES__description} {#representation |!}{SMILES#}, the molecule has a {half_life_duration__names__noun} of {half_life_duration#} {half_life_duration__units}.
2-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3-thiazole-4-carboxamide